169 studies found for:    "psoriatic arthritis"
Show Display Options
Rank Status Study
21 Recruiting Etanercept and Methotrexate in Combination or as Monotherapy in Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: Etanercept + Oral Methotrexate;   Drug: Etanercept + Placebo for Methotrexate;   Drug: Oral Methotrexate + Placebo for Etanercept
22 Completed Multiple Dose Study of UCB4940 in Subjects With Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: UCB4940 40 mg;   Drug: UCB4940 80 mg;   Drug: UCB4940 160 mg;   Drug: UCB4940 240 mg;   Drug: UCB4940 320 mg;   Drug: UCB4940 560 mg;   Other: Placebo
23 Completed A 24 Week Open Label Study of the Utility of Adalimumab in Active Axial Forms of Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention: Drug: Adalimumab (HUMIRA®)
24 Active, not recruiting
Has Results
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: Apremilast 20mg;   Drug: Apremilast 30mg;   Drug: Placebo + 20 mg Apremilast;   Drug: Placebo + 30 mg Apremilast
25 Active, not recruiting Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
Condition: Psoriatic Arthritis
Interventions: Drug: Tofacitinib 5 mg BID;   Drug: Tofacitinib 10 mg BID;   Drug: Adalimumab;   Drug: Placebo
26 Completed Safety and Tolerability of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention: Biological: AIN457A
27 Recruiting Special Investigation in Patients With Psoriatic Arthritis (PsA) (Working Productivity and Activity Impairment (WPAI))
Condition: Psoriatic Arthritis
Intervention:
28 Completed
Has Results
Efficacy and Safety of Humira® in Patients With Psoriatic Arthritis in Normal Medical Practice
Condition: Psoriatic Arthritis
Intervention:
29 Completed
Has Results
An Effectiveness and Safety Study of CNTO 1275 in Patients With Active Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: CNTO 1275 63 mg;   Drug: Placebo
30 Unknown  Protocol for H.P. Acthar Gel in Moderately to Severely Active Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention: Drug: Open  label H.P. Acthar Gel
31 Completed Study Evaluating Anxiety and Depression in Patients With Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention:
32 Recruiting Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Active Psoriatic Arthritis (PsA)
Condition: Psoriatic Arthritis
Interventions: Drug: Guselkumab;   Drug: Ustekinumab;   Drug: Placebo
33 Active, not recruiting
Has Results
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (PsA)
Condition: Psoriatic Arthritis
Interventions: Drug: Apremilast 20mg;   Drug: Apremilast 30mg;   Drug: Placebo;   Drug: Placebo + 20mg Apremilast;   Drug: Placebo + 30mg Apremilast
34 Active, not recruiting 24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Biological: Secukinumab;   Biological: Placebo
35 Terminated Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: 210 mg brodalumab;   Drug: 140 mg brodalumab;   Drug: Placebo
36 Active, not recruiting Extension Study up to 3 Years for Secukinumab in Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention: Drug: Secukinumab
37 Completed A Placebo-controlled Study With an Extension Examining the Safety and Efficacy of Alefacept in Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: Alefacept;   Drug: Methotrexate;   Drug: Placebo
38 Active, not recruiting To Observe the Impacts of Anti-Tumor Necrosis Factor (TNF) Effectiveness on Improvement in Work Place and Household Productivity for Patients With Psoriatic Arthritis
Conditions: Psoriatic Arthritis;   Work Productivity
Intervention:
39 Completed Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthritis (PsA)
Condition: Psoriatic Arthritis
Intervention: Drug: adalimumab
40 Completed
Has Results
Prevalence and Incidence of Articular Symptoms and Signs Related to Psoriatic Arthritis in Patients With Psoriasis Severe or Moderate With Adalimumab Treatment
Conditions: Psoriasis;   Psoriatic Arthritis
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years